THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK V. MYLAN PHARMACEUTICALS INC. , No. 12-1523 (Fed. Cir. 2012)

 Annotate this Case
Download PDF
Case: 12-1523 Document: 43 Page: 1 Filed: 10/15/2012 NOTE: This order is nonprecedential. Wntteb ~tate~ «ourt of ~peaI~ for tbe jfeberaI «treutt THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND NEW YORK UNIVERSITY, Plaintiff-Cross Appellant, AND GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellant, MYLAN PHARMACEUTICALS INC., Plaintiff-Appellant, v. GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Defendants-Cross Appellants, AND SUPERNUS PHARMACEUTICALS, INC., Defendant-Appellee. Case: 12-1523 Document: 43 Page: 2 Filed: 10/15/2012 RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS 2 2012-1523, -1524, -1555, -1556, -1557 Appeals from the United States District Court for the District of Delaware in case nos. 09-CV-0184 and 10-CV0892, Judge Leonard P. Stark. THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND SUPERNUS PHARMACEUTICALS, INC., Plaintiff-Appellee, AND NEW YORK UNIVERSITY, Plaintiff-Cross Appellant, AND GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants v. IMPAX LABORATORIES, INC., Defendant-Appellant. 2012-1545, -1546, -1590, -1591, -1592 Case: 12-1523 3 Document: 43 Page: 3 Filed: 10/15/2012 RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS Appeals from the United States District Court for the District of Delaware in case nos. 09-CV-0703 and 11-CV0477, Judge Leonard P. Stark. GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants, AND SUPERNUS PHARMACEUTICALS, INC., Plaintiff-Appellee, v. LUPIN LIMITED AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants. 2012-1566, -1596 Appeals from the United States District Court for the District of Delaware in case no. 10-CV-1112, Judge Leonard P. Stark. THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND NEW YORK UNIVERSITY, Plaintiff-Appellant, AND Case: 12-1523 Document: 43 Page: 4 Filed: 10/15/2012 RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS 4 GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Appellants v. LUPIN LIMITED AND LUPIN PHARMACEUTICALS, INC., Defendants-Cross Appellants. 2012-1597, -1598, -1599 Appeals from the United States District Court for the District of Delaware in case no. 09-CV-0483, Judge Leonard P. Stark. ON MOTION ORDER Upon consideration of Galderma Laboratories Inc., et al.'s unopposed motions to consolidate the above captioned appeals and set the briefing schedule, IT Is ORDERED THAT: (1) The motions are granted. Mylan Pharmaceuticals, Inc., Impax Laboratories, Inc., Lupin Limited, and Lupin Pharmaceuticals, Inc.'s principal briefs are due October 1, 2012. Galderma Laboratories Inc., Galderma Laboratories, L.P., Supernus Pharmaceuticals, Inc., and New York University's principal and response briefs are due November 13, 2012. Mylan, Impax, and Lupin's re- Case: 12-1523 5 Document: 43 Page: 5 Filed: 10/15/2012 RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS sponse/reply briefs are due December 26,2012. Galderma and New York University's reply briefs are due January 11,2013. (2) The revised official caption is reflected above. FOR THE COURT /s/ Jan Horbaly Jan Horbaly Clerk s26

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.